Amber Therapeutics: Landmark $100M Series A | LSI Europe '24

This keynote took place at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.

Led by Henry Peck, Aidan Crawley shares the story of Amber Therapeutics massive $100M Series A alongside several VCs who talk about the motivations behind the funding round.

This keynote featured:

Henry Peck — LSI

Aidan Crawley — Amber Therapeutics

Murielle Thinard McLane — Intuitive Ventures

Liliane Chamas — Oxford Science Enterprises

Caroline Gaynor — Lightstone Ventures

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

Follow us on social:

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw